Your browser doesn't support javascript.
loading
Molecular characterization of linezolid-resistant CoNS isolates in Japan.
Takaya, Akiko; Kimura, Asahi; Sato, Yoshiharu; Ishiwada, Naruhiko; Watanabe, Masaharu; Matsui, Mari; Shibayama, Keigo; Yamamoto, Tomoko.
Afiliação
  • Takaya A; Department of Microbiology and Molecular Genetics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
  • Kimura A; Department of Microbiology and Molecular Genetics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
  • Sato Y; Department of Microbiology and Molecular Genetics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
  • Ishiwada N; Division of Control and Treatment of Infectious Diseases, Chiba University Hospital, Chiba 260-8677, Japan.
  • Watanabe M; Division of Laboratory Medicine, Chiba University Hospital, Chiba 260-8677, Japan.
  • Matsui M; Department of Bacteriology II, National Institute of Infectious Diseases, Musashimurayama, Tokyo 208-0011, Japan.
  • Shibayama K; Department of Bacteriology II, National Institute of Infectious Diseases, Musashimurayama, Tokyo 208-0011, Japan.
  • Yamamoto T; Department of Microbiology and Molecular Genetics, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan tomoko-y@faculty.chiba-u.jp.
J Antimicrob Chemother ; 70(3): 658-63, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25381168
ABSTRACT

OBJECTIVES:

Linezolid has been reported to remain active against 98% of staphylococci with resistance identified in 0.05% of Staphylococcus aureus and 1.4% of CoNS. The objective of this study was to characterize the linezolid-resistance mechanisms in the linezolid-resistant CoNS strains isolated in Japan.

METHODS:

Staphylococcus capitis strains exhibiting linezolid MICs >8 mg/L isolated from inpatients between 2012 and 2014 were screened for cfr and mutations in 23S rRNA, L3 and L4 by PCR/sequencing. Isolates were also examined for mutations in the rlmN gene.

RESULTS:

S. capitis had six 23S rRNA alleles. Five S. capitis isolates displayed linezolid MICs of 8, 16 and 32 mg/L. G2576U mutations were detected in three, four or five copies of 23S rRNA in all isolates. In two isolates exhibiting the highest linezolid MIC (32 mg/L) there was a large deletion in a single copy of 23S rRNA. Repeated 10 bp sequences were found in both 16S and 23S rRNAs, suggesting deletion by recombination between the repeats. One isolate had the mutation Ala-142→Thr in the ribosomal protein L3. All linezolid-resistant isolates also demonstrated mutations in the gene encoding RlmN methyltransferase, leading to Thr-62→Met and Gly-148→Ser.

CONCLUSIONS:

Multiple mechanisms appeared to be responsible for the elevated linezolid resistance in S. capitis isolates a G2576U mutation in different numbers of copies of 23S rRNA, loss of a single copy of 23S rRNA and a mutation in the ribosomal protein L3, suggesting the accumulation of independent mutational events.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Staphylococcus / Oxazolidinonas / Acetamidas / Antibacterianos / Mutação Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Staphylococcus / Oxazolidinonas / Acetamidas / Antibacterianos / Mutação Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article